share_log

中国抗体-B完成发行合共851.26万股认购股份

China Antibody-B completed the issuance of a total of 8.512,600 subscribed shares

新浪港股 ·  Jan 31 19:53

China Antibody-B (03681) announced that since the prerequisites contained in the remaining two subscription agreements have been met, the two subscription agreements were completed on January 31, 2024 in accordance with the terms and conditions of the relevant subscription agreements. A total of 8,512,600 shares, which is equivalent to approximately 0.79% of the company's issued share capital immediately before completing the remaining two subscription agreements; and approximately 0.78% of the company's issued share capital expanded by issuing subscription shares, which have been issued to subscribers at a subscription price of HK$1.29 per subscribed share. The net proceeds from the subscription process of approximately HK$10.9813 million will be applied as disclosed in the announcement.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment